FindTrial
Sign In

Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer

Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer - Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060642
Enrollment
50
Registered
2026-03-01
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial carcinoma

Interventions

Right subphrenic cytology will be uniformly added for all cases.

Sponsors

National Hospital Organization (NHO) Shikoku Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Diagnosed with endometrial cancer preoperatively 2) Scheduled to undergo robot-assisted surgery 3) Provided written informed consent to participate in this study 4) Age 18 years or older at the time of consent

Exclusion criteria

Exclusion criteria: 1) Patients deemed inappropriate for inclusion in this study by the attending physician 2) Patients with uterine sarcoma 3) Patients who have received preoperative chemotherapy 4) Women who are pregnant or may be pregnant

Design outcomes

Primary

MeasureTime frame
Pathological Evaluability Rate of Right Subphrenic Cytology—

Countries

Japan

Contacts

Public ContactTakanori Yokoyama

NHO Shikoku Cancer Center Gynecology

yokoyama.takanori.dk@mail.hosp.go.jp089-999-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026